Lyase to live by: Sphingosine phosphate lyase as a therapeutic target

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 8, 2009, Pages 1013-1025

  Kumar, Ashok ^a   Saba, Julie D ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

FTY720; s1p lyase; Sgpl1; Sphingolipid; Sphingosine 1 phosphate lyase

Indexed keywords

1 DESOXYDIHYDROSPHINGOSINE 1 PHOSPHONATE; 2 VINYLDIHYDROSPHINGOSINE 1 PHOSPHATE; [2 HYDROXY 1 HYDROXYMETHYL 2 (2 TRIDECYL 1 CYCLOPROPENYL)ETHYL]OCTANAMIDE; BISULFITE; CERAMIDE; CYANIDE; DEOXYPYRIDOXINE; FINGOLIMOD; L 2931; LX 2931; LYASE; SEMICARBAZIDE; SPHINGOLIPID; SPHINGOSINE PHOSPHATE LYASE; UNCLASSIFIED DRUG;

APOPTOSIS; BIOCHEMISTRY; BLOOD BRAIN BARRIER; CANCER GROWTH; CARCINOGENESIS; CATABOLISM; CATALYSIS; CELL DEATH; CELL PROLIFERATION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DISEASE ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME STRUCTURE; GRAFT REJECTION; HUMAN; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TISSUE DISTRIBUTION; VASCULAR DISEASE;

ALDEHYDE-LYASES; ANIMALS; AUTOIMMUNE DISEASES; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; GENE TARGETING; HUMANS; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION;

EID: 69149089682     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903039722     Document Type: Review

References (125)

1. Alvarez SE, Milstien S, Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 2007;18(8):300-307
2. Takabe K, Paugh SW, Milstien S, Spiegel S. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008;60(2):181-195
3. Karliner JS. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J Cardiovasc Pharmacol 2009;53(3):189-197
4. Van Brocklyn JR, Lee MJ, Menzeleev R, et al. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 1998;142(1):229-240 (Pubitemid 28341153)
5. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998;279(5356):1552- 1555 • A pivotal study that identified G-protein coupled receptor (Endothelial Differentiation Gene-1 ) as first S1P receptor. (Pubitemid 28217081)
6. Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S. Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem 2009 published online 20 Feb 2009, doi:10.1146/ annurev.biochem.78.072407.103733
7. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008;8(10):753-763
8. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004;427(6972):355-360 •• A seminal study showing the important role of S1P1 receptor in lymphocyte egress from thymus and secondary lymphoid organs. (Pubitemid 38133663)
9. Kohama T, Olivera A, Edsall L, et al. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 1998;273:23722-23728 (Pubitemid 28435703)
10. Liu H, Sugiura M, Nava VE, et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000;275(26):19513-19520 (Pubitemid 30441543)
11. Mandala SM, Thornton R, Tu Z, et al. Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. Proc Natl Acad Sci USA 1998;95(1):150-155 (Pubitemid 28103922)
12. Saba JD, Nara F, Bielawska A, et al. The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J Biol Chem 1997;272(42):26087-26090 • The first study, to our knowledge, to clone a SPL gene. (Pubitemid 27458813)
13. Zhou J, Saba J. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem Biophys Res Commun 1998;242(3):502-507 (Pubitemid 28412556)
14. Van Veldhoven PP, Gijsbers S, Mannaerts GP, et al. Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22. Biochim Biophys Acta 2000;1487:128-134
15. Gottlieb D, Heideman W, Zhou J, et al. The DPL1 gene is involved in mediating the response to nutrient deprivation in Saccharomyces cerevisiae. Mol Cell Biol Res Commun 1999;1:66-71 (Pubitemid 129532295)
16. Mendel J, Heinecke K, Fyrst H, Saba JD. Sphingosine phosphate lyase expression is essential for normal development in Caenorhabditis elegans. J Biol Chem 2003;278(25):22341-22349 (Pubitemid 36830283)
17. Herr DR, Fyrst H, Phan V, et al. Sply regulation of sphingolipid signaling molecules is essential for Drosophila development. Development 2003;130(11):2443-2453 (Pubitemid 36722395)
18. Reiss U, Oskouian B, Zhou J, et al. Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J Biol Chem 2004;279(2):1281-1290 (Pubitemid 38082652)
19. Fyrst H, Saba JD. Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight. Biochim Biophys Acta 2008;1781(9):448-458 • An excellent review that describes structure, enzyme kinetics and tissue distribution of SPL and its role in development and diseases.
20. Schwab S, Pereira J, Matloubian M, et al. Lymphocyte sequestration through S1P lyase inhibition an disruption of S1P gradients. Science 2005;309:1735-1739 • A pivotal study showing the important role of SPL in lymphocyte trafficking. (Pubitemid 41285945)
21. Oskouian B, Sooriyakumaran P, Borowsky A, et al. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is downregulated in colon cancer. Proc Natl Acad Sci USA 2006;103:17384-17389 • An important study that implicates SPL's in death and tumor suppression. (Pubitemid 44788978)
22. Zhang K, Pompey J, Hsu F, et al. Redirection of sphingolipid metabolism towards de novo synthesis of ethanolamine in Leishmania. EMBO J 2007;26:1094-1104 (Pubitemid 46303588)
23. Van Veldhoven PP, Mannaerts GP. Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver. J Biol Chem 1991;266:12502-12507 (Pubitemid 21907123)
24. Ikeda M, Kihara A, Igarashi Y. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5′-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun 2004;325:338-343 (Pubitemid 39441198)
25. Dobrosotskaya I, Seegmiller A, Brown M, et al. Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 2002;296(5569):879-883 (Pubitemid 34464887)
26. Kariya Y, Kihara A, Ikeda M, et al. Products by the sphingosine kinase/ sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. Genes Cells 2005;10(6):605-615 (Pubitemid 40867491)
27. Li G, Foote C, Alexander S, Alexander H. Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. Development 2001;128(18):3473-3483 (Pubitemid 32962716)
28. Nishikawa M, Hosokawa K, Ishiguro M, et al. Degradation of sphingoid long-chain base 1-phosphates (LCB-1Ps): functional characterization and expression of AtDPL1 encoding LCB-1P lyase involved in the dehydration stress response in Arabidopsis. Plant Cell Physiol 2008;49(11):1758-1763
29. Mukhopadhyay D, Howell KS, Riezman H, Capitani G. Identifying key residues of sphinganine-1-phosphate lyase for function in vivo and in vitro. J Biol Chem 2008;283(29):20159-20169
30. Genter MB, Van Veldhoven PP, Jegga AG, et al. Microarray-based discovery of highly expressed olfactory mucosal genes: potential roles in the various functions of the olfactory system. Physiol Genomics 2003;16(1):67-81
31. Yatomi Y, Igarashi Y, Yang L, et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 1997;121(5):969-973 (Pubitemid 27236918)
32. Ito K, Anada Y, Tani M, et al. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun 2007;357:212-217 (Pubitemid 46574517)
33. Vesper H, Schmelz E, Nikolova-Karakashian M, et al. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 1999;129:1239-1250 (Pubitemid 29304970)
34. Oskouian B, Mendel J, Shocron E, et al. Regulation of sphingosine-1-phosphate lyase gene expression by members of the GATA family of transcription factors. J Biol Chem 2005;280(18):18403-18410 (Pubitemid 41389089)
35. Chen W, Delrow J, Corrin P, et al. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat Genet 2004;36:304-312 (Pubitemid 38282758)
36. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 2006;81(9):1241-1257 (Pubitemid 44316290)
37. Schmahl J, Raymond C, Soriano P. PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 2007;39(1):52-60 (Pubitemid 46026501)
38. Shi XB, Xue L, Yang J, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA 2007;104(50):19983-19988
39. Hutton J, Jegga A, Kong S, et al. Microarray and comparative genomic-based identification of genes and gene regulatory regions of the mouse immune system. BMC Genomics 2004;5:82. Published online 25 October 2004, doi:10.1186/1471-2164-5-82 (Pubitemid 39565302)
40. Dannenberg JH, David G, Zhong S, et al. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev 2005;19(13):1581-1595 (Pubitemid 41003001)
41. Zhan X, Desiderio DM. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal Biochem 2006;354(2):279-289 (Pubitemid 43913574)
42. Huang H, Lee T, Tzeng S, Horng J. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acid Res 2005;33:W226-9 (Pubitemid 44529913)
43. Vogel P, Donoviel MS, Read R, et al. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS ONE 2009;4(1):e4112. Published online, January 1, 2009, e4112. doi:10.1371/journal.pone.0004112
44. Saddoughi SA, Song P, Ogretmen B. Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 2008;49:413-440
45. Huwiler A, Pfeilschifter J. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. Curr Pharm Des 2006;12(35):4625-4635 (Pubitemid 44835150)
46. Li G, Alexander H, Schneider N, Alexander S. Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium. Microbiology 2000;146(Pt 9):2219-2227 (Pubitemid 30702349)
47. Min J, Stegner A, Alexander H, Alexander S. Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs. Eukaryot Cell 2004;3(3):795-805 (Pubitemid 38763866)
48. Min J, Van Veldhoven PP, Zhang L, et al. Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol Cancer Res 2005;3(5):287-296 (Pubitemid 40656816)
49. Bhat G, Sea T, Olatinwo M, et al. Influence of a leptin deficiency on testicular morphology, germ cell apoptosis, and expression levels of apoptosis-related genes in the mouse. J Androl 2006;27(2):302-310 (Pubitemid 43306110)
50. Phan VH, Herr DR, Panton D, et al. Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila. Dev Biol 2007;309(2):329-341 (Pubitemid 47361116)
51. Fyrst H, Zhang X, Herr D, et al. Identification and characterization by electrospray mass spectrometry of endogenous Drosophila sphingadienes. J Lipid Res 2008;49(3):597-606 • In this study authors have identified novel endogenous sphingadienes that accumulates in sply mutant flies.
52. Hagen N, Van Veldhoven PP, Proia RL, et al. Subcellular origin of sphingosine-1-phosphate is essental for its toxic effect in lyase deficient neurons. J Biol Chem 2009;284(17):11346-11353
53. Shida D, Takabe K, Kapitonov D, et al. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 2008;9(8):662-673
54. Xia P, Gamble JR, Wang L, et al. An oncogenic role of sphingosine kinase. Curr Biol 2000;10(23):1527-1530
55. Kawamori T, Kaneshiro T, Okumura M, et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J 2009;23(2):405-414
56. Cuvillier O. Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets 2008;12(8):1009-1020
57. Lawlor ER, Soucek L, Brown-Swigart L, et al. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 2006;66(9):4591-4601
58. Li Z, Van Calcar S, Qu C, et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 2003;100(14):8164-8169 (Pubitemid 36842516)
59. Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem 2009;55(3):425-438
60. Knowles LM, Smith JW. Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer. BMC Genomics 2007;8:168. Published online 12 June 2007, doi:10.1186/1471-2164-8-168
61. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33(1):49-54 (Pubitemid 36068681)
62. Visentin B, Vekich J, Sibbald B, et al. Validation of an anti-sphingosine-1- phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 2006;9:225-238 (Pubitemid 43357948)
63. Hibbs K, Skubitz K, Pambuccian S, et al. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 2004;165:397-414 (Pubitemid 38971371)
64. Bernardini M, Lee CH, Beheshti B, et al. High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia 2005;7(6):603-613 (Pubitemid 40967761)
65. Xu Y, Xiao Y, Baudhuin L, Schwartz B. The role and clinical applications of bioactive lysolipids in ovarian cancer. J Soc Gynecol Investig 2001;8:1-13
66. Paris F, Perez G, Fuks Z, et al. Sphingosine-1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med 2002;8:901-902 (Pubitemid 35033673)
67. Tilly J, Kolesnick R. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim Biophys Acta 2002;1585:135-138 (Pubitemid 36092077)
68. Rosen H, Sanna MG, Cahalan SM, Gonzalez-Cabrera PJ. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol 2007;28(3):102-107 (Pubitemid 46283694)
69. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002;296(5566):346-349 •• A landmark study that showed that immunomodulator drug FTY720 is a S1P receptor agonist. (Pubitemid 34303689)
70. Kharel Y, Lee S, Snyder AH, et al. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem 2005;280(44):36865-36872 (Pubitemid 41587768)
71. Zemann B, Kinzel B, Muller M, et al. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 2006;107(4):1454-1458 (Pubitemid 43242381)
72. Bandhuvula P, Tam Y, Oskouian B, Saba J. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J Biol Chem 2005;280:33697-33700 • This study shows that immunomodulator compound FTY720 is an inhibitor of SPL. (Pubitemid 41443086)
73. Rosen H, Goetzl E. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 2005;5:560-570 (Pubitemid 40961333)
74. Jin Y, Knudsen E, Wang L, et al. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 2003;101(12):4909-4915 (Pubitemid 36857753)
75. Dorsam G, Graeler MH, Seroogy C, et al. Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J Immunol 2003;171(7):3500-3507 (Pubitemid 37254552)
76. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359(9313):1221-1231
77. Fujino M, Funeshima N, Kitazawa Y, et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003;305(1):70-77 (Pubitemid 36378136)
78. Foster CA, Mechtcheriakova D, Storch MK, et al. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 2009;19(2):254-266
79. Kappos L, Antel J, Comi G, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006;355:1124-1140 (Pubitemid 44394919)
80. Laychock S, Sessanna S, Lim M, Mastrandrea L. Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet β-cells. Endocrinology 2006;147:4705-4712 (Pubitemid 44402178)
81. Maki T, Gottschalk R, Ogawa N, Monaco AP. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. Transplantation 2005;79(9):1051-1055 (Pubitemid 40663996)
82. + T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Diabetes 2008;57(2):484-493
83. Xia P, Wang L, Moretti PA, et al. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J Biol Chem 2002;277(10):7996-8003 (Pubitemid 34968251)
84. Pettus BJ, Bielawski J, Porcelli AM, et al. The sphingosine kinase 1/sphingosine-1- phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α. FASEB J 2003;17(11):1411-1421 (Pubitemid 36939148)
85. Lai WQ, Irwan AW, Goh HH, et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 2008;181(11):8010-8017
86. Hughes JE, Srinivasan S, Lynch KR, et al. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008;102(8):950-958 (Pubitemid 351591554)
87. Seo EY, Park GT, Lee KM, et al. Identification of the target genes of atopic dermatitis by real-time PCR. J Invest Dermatol 2006;126(5):1187-1189
88. Holleran W, Takagi Y, Uchida Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006;580:5456-5466 (Pubitemid 44465907)
89. Reines I, Kietzmann M, Mischke R, et al. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol 2009 published online, 5 February 2009; doi:10.1038/jid.2008.454
90. van der Giet M, Tolle M, Kleuser B. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. Biol Chem 2008;389(11):1381-1390
91. Venkataraman K, Lee Y, Michaud J, et al. Vascular endothelium as a contributor of plasma sphingosine-1-phosphate. Circ Res 2008;102(6):669-676
92. Komarova YA, Mehta D, Malik AB. Dual regulation of endothelial junctional permeability. Sci STKE 2007;2007(412):re8. Published online 13 November 2007, DOI: 10.1126/stke.4122007re8
93. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999;99(3):301-312 (Pubitemid 29519909)
94. Sanna M, Wang S, Gonzalez-Cabrera P, et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol 2006;2:434-441 (Pubitemid 44114922)
95. Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Res Crit Care Med 2004;169(11):1245-1251 (Pubitemid 38680403)
96. Tauseef M, Kini V, Knezevic N, et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1- phosphate receptor signaling in endothelial cells. Circ Res 2008;103(10):1164- 1172
97. Gon Y, Wood MR, Kiosses WB, et al. S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc Natl Acad Sci USA 2005;102(26):9270-9275 (Pubitemid 40923553)
98. Watkins SA, Zippin JH. When wound healing goes awry. A review of normal and abnormal wound healing, scar pathophysiology, and therapeutics. J Drugs Dermatol 2008;7(10):997-1005
99. Liu ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008;10(11):1869-1882
100. Kawanabe T, Kawakami T, Yatomi Y, et al. Sphingosine-1-phosphate accelerates wound healing in diabetic mice. J Dermatol Sci 2007;48:53-60 (Pubitemid 47284808)
101. Serriere-Lanneau V, Teixeira-Clerc F, Li L, et al. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J 2007;21:2005-2013 (Pubitemid 47026436)
102. Schmahl J, Rizzolo K, Soriano P. The PDGF signaling pathway controls multiple steroid-producing lineages. Genes Dev 2008;22(23):3255-3267
103. Donati C, Meacci E, Nuti F, et al. Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor. FASEB J 2005;19(3):449-451 (Pubitemid 40316546)
104. Bruni P, Donati C. Pleiotropic effects of sphingolipids in skeletal muscle. Cell Mol Life Sci 2008;65(23):3725-3736
105. Means CK, Brown JH. Sphingosine 1-phosphate receptor signalling in the heart. Cardiovasc Res 2009;82(2):193-200
106. Zanin M, Germinario E, Dalla Libera L, et al. Trophic action of sphingosine 1-phosphate in denervated rat soleus muscle. Am J Physiol Cell Physiol 2008;294(1):C36-46
107. Porter J, Khanna S, Kaminski H, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002;11:263-272 (Pubitemid 34173355)
108. Sanna MG, Liao J, Jo E, et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004;279(14):13839-13848 (Pubitemid 38468916)
109. Schmouder R, Serra D, Wang Y, et al. FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects. J Clin Pharmacol 2006;46(8):895-904 (Pubitemid 44050826)
110. Sugiyama A, Yatomi Y, Ozaki Y, Hashimoto K. Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc Res 2000;46:119-125 (Pubitemid 30155952)
111. Deutschman DH, Carstens JS, Klepper RL, et al. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 2003;146(1):62-68 (Pubitemid 36851301)
112. Means C, Xiao C, Li Z, et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007;292(6):H2944-51 (Pubitemid 47084545)
113. Jin ZQ, Goetzl EJ, Karliner JS. Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation 2004;110(14):1980-1989
114. Katsel P, Li C, Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 2007;32(4-5):845-856
115. He X, Huang Y, Li B, et al. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 2008 published online 10 June 2008, doi:10.1016/j.neurobiolaging.2008.05.010
116. Morgan AR, Turic D, Jehu L, et al. Association studies of 23 positional/ functional candidate genes on chromosome 10 in late-onset alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2007;144B(6):762-770 (Pubitemid 47417205)
117. Stoffel W, Grol M. Chemistry and biochemistry of 1-desoxysphinganine 1-phosphonate (dihydrosphingosine-1- phosphonate). Chem Phys Lipids 1974;13:372-388
118. Boumendjel A, Miller S. Synthesis of sphingosine-1-phosphate and dihydrosphingosine-1-phosphate. J Lipid Res 1994;35(12):2305-2311
119. Triola G, Fabrias G, Dragusin M, et al. Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy- 1-hydroxymethyl-2-(2- tridecyl-1- cyclopropenyl)ethyl]octanamide (GT11) in primary cultured cerebellar neurons. Mol Pharmacol 2004;66(6):1671-1678 (Pubitemid 39564795)
120. Mulgaonkar S, Tedesco H, Oppenheimer F, et al. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study. Am J Transplant 2006;6(8):1848-1857 (Pubitemid 44024956)
121. Salvadori M, Budde K, Charpentier B, et al. FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. Am J Transplant 2006;6(12):2912-2921 (Pubitemid 44777921)
122. Tedesco-Silva H, Szakaly P, Shoker A, et al. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study. Transplantation 2007;84(7):885-892 (Pubitemid 351338950)
123. Available from: http://www.lexicongenetics. com/pipeline/lx2931-lx2932. html
124. Oravecz T, Donoviel MS, Anderson SJ, et al. Genetic and chemical inhibition of sphingosine-1-phosphate lyase results in peripheral lymphopenia and alleviates disease development in animal models of inflammation and autoimmunity. Annual Meeting of the American Society of Hematology 2007. Available from: http://www.lexgen.com/images/pdfs/LX2931-ASH-2007.pdf [Last accessed28 May 2009]
125. Brown P, Frazier K, Augeri D, et al. LX2931: a potential small molecule treatment for autoimmune disorders. Annual Meeting of the American College of Rheumatology 2008, Available from: http://www.lexgen.com/images/pdfs/clinical- 2008-acr-poster-final.pdf [Last accessed 29 May 2009]